Page 382 - Read Online
P. 382

Elsayed et al. Vessel Plus 2018;2:39  I  http://dx.doi.org/10.20517/2574-1209.2018.65                                                  Page 5 of 11

               Table 2. Intraoperative and postoperative data
               Variables                                               No. (%), mean ± SD, or median (range) (n = 30)
               Number of distal anastomosis     1                                  6 (20)
                                                2                                  6 (20)
                                                3                                  12 (40)
                                                4                                  6 (20)
               Cross clamp time (min)                                              60.7 ± 17.82
                                                                                   60 (28.0-100.0)
               Method of reconstruction         LIMA patch                         22 (73.3)
                                                SVG patch + LIMA                   8 (26.7)
               Length of reconstruction (cm)                                       6.35 ± 1.47
                                                                                   6 (5-10)
               Time of ventilation (h)                                             6 (3-110)
               Inotropic support (days)                                            2.40 ± 0.93
               ICU stay (days)                                                     4.93 ± 1.41
               Myocardial infarction                                               2 (6.7)
               Need for dialysis                                                   0 (0)
               Stroke                                                              0 (0)
               Atrial fibrillation                                                 7 (23.3)
               Mediastinitis                                                       1 (3.3)
               Bleeding requiring exploration                                      2 (6.7)
               Mortality                                                           1 (3.3)

               LIMA: left internal mammary artery; SVG: saphenous vein graft

               Table 3. Follow up and CT angiographic patency
               Variables                                           No. (%), mean ± SD, or median (range) (n = 29)
               Duration of follow up (months)                                17.59 ± 6.34
                                                                             20.0 (6.0-26.0)
               Post operative ejection fraction                              56.28 ± 5.62
                                                                             58.0 (48.0-68.0)
               Post op. NYHA class
                 I                                                           20 (69.0)
                 II                                                          9 (31.0)
               LIMA LAD CT angio patency
                 Patent                                                      27 (93.1)
                 Postoperative angina                                        4 (13.8)
                 GI bleeding                                                 1 (3.4)
               Medications
                 Plavix aspirin                                              12 (41.4)
                 Plavix aspirin + marevan                                    17 (58.6)

               NYHA: New York Heart Association; LIMA: left internal mammary artery; LAD: left anterior descending artery; GI: gastrointestinal


               DISCUSSION
               Complete revascularization of coronary vessels is the main target of CABG and in particular the LIMA-
               LAD anastomosis, since a patent LIMA-LAD is the single most important determinant of the long-term and
                               [4]
               event-free survival .
               With advances in PCI, patients now referred to CABG are becoming more complex with multiple
               comorbidities as well as less attractive target vessels. Diffuse coronary artery disease is a problem that faces
               surgeons now with increasing frequency since in this subset of patients PCI produces less than optimal
                     [5]
               results . In up to 25% of patients with diffuse coronary disease conventional CABG as well would not
                                                        [6]
               optimally revascularize the ischemic territories . Therefore endarterectomy was revisited as an option to
               increase the surgical armamentarium in facing this complex lesion.
   377   378   379   380   381   382   383   384   385   386   387